Home › Type 1 Diabetes › Washington › Seattle
Type 1 Diabetes clinical trials in Seattle, WA
18 studies for Type 1 Diabetes are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Type 1 Diabetes Extension Study
RecruitingObservational study
- Benaroya Research Institute, Seattle
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
RecruitingPhase 2
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
RecruitingPhase 3
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
RecruitingPhase 1/2
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
RecruitingPhase 2
- Benaroya Research Institute, Seattle
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
RecruitingPhase 2
- Benaroya Research Institute, Seattle
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
RecruitingPhase 1/2
- Seattle Children's Hospital, Seattle
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
RecruitingPhase 2
- Benaroya Research Institute at Virginia Mason, Seattle
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
Recruiting
- University of Washington, Seattle
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
RecruitingPhase 2
- University of Washington, Seattle
Kidney Precision Medicine Project
RecruitingObservational study
- University of Washington, Seattle
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
RecruitingPhase 3
- University of Washington, Seattle
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
RecruitingPhase 3
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
Recruiting
- Seattle Children's, Seattle
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
RecruitingObservational study
- Benaroya Research Institute, Seattle
InvesT1D: Promoting Adolescent Investment in Diabetes Care
Recruiting
- Seattle Children's, Seattle
TrialNet Pathway to Prevention of T1D
RecruitingObservational studyHealthy volunteers welcome
- Benaroya Research Institute, Seattle
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RecruitingPhase 1
- Seattle Children's Hospital, Seattle
About Type 1 Diabetes
If the pancreas doesn't make needed insulin, causing blood sugar levels to be too high you have type 1 or juvenile diabetes. Learn the signs.
More about Type 1 Diabetes on MedlinePlus
Type 1 Diabetes trials in other cities
- Aurora, CO23 studies
- Boston, MA21 studies
- Chicago, IL16 studies
- New York City, NY15 studies
- New Haven, CT15 studies
- San Francisco, CA14 studies
- Miami, FL13 studies
- Indianapolis, IN13 studies
- Gainesville, FL12 studies
- Philadelphia, PA11 studies
- Atlanta, GA11 studies
- Durham, NC10 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Multiple Myeloma22 studies
- Pancreatic Cancer22 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.